BSE Live
Sep 10, 10:34Prev. Close
6000.05
Open Price
6059.85
Bid Price (Qty.)
5960.55 (5)
Offer Price (Qty.)
5967.95 (2)
NSE Live
Sep 10, 10:34Prev. Close
6002.50
Open Price
6015.00
Bid Price (Qty.)
5964.00 (100)
Offer Price (Qty.)
5964.50 (4)
Key Financial Ratios of Divis Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 83.20 | 59.37 | 68.11 | 111.07 | 73.63 | |
Diluted EPS (Rs.) | 83.20 | 59.37 | 68.11 | 111.07 | 73.63 | |
Cash EPS (Rs.) | 98.49 | 73.66 | 81.00 | 122.78 | 83.23 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 562.08 | 508.83 | 478.64 | 440.44 | 349.28 | |
Book Value [InclRevalReserve]/Share (Rs.) | 562.08 | 508.83 | 478.64 | 440.44 | 349.28 | |
Dividend / Share(Rs.) | 30.00 | 30.00 | 30.00 | 30.00 | 20.00 | |
Revenue from Operations/Share (Rs.) | 347.09 | 289.25 | 287.26 | 334.52 | 256.12 | |
PBDIT/Share (Rs.) | 125.70 | 94.75 | 101.59 | 150.22 | 108.62 | |
PBIT/Share (Rs.) | 110.57 | 80.57 | 88.70 | 138.53 | 99.02 | |
PBT/Share (Rs.) | 110.53 | 80.45 | 88.68 | 138.50 | 99.00 | |
Net Profit/Share (Rs.) | 83.36 | 59.47 | 68.12 | 111.08 | 73.64 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 36.21 | 32.75 | 35.36 | 44.90 | 42.40 | |
PBIT Margin (%) | 31.85 | 27.85 | 30.87 | 41.41 | 38.66 | |
PBT Margin (%) | 31.84 | 27.81 | 30.87 | 41.40 | 38.65 | |
Net Profit Margin (%) | 24.01 | 20.56 | 23.71 | 33.20 | 28.75 | |
Return on Networth / Equity (%) | 14.83 | 11.68 | 14.23 | 25.21 | 21.08 | |
Return on Capital Employed (%) | 19.02 | 15.13 | 17.73 | 30.29 | 27.28 | |
Return on Assets (%) | 13.13 | 10.25 | 12.59 | 22.15 | 18.22 | |
Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover Ratio (%) | 0.57 | 0.52 | 0.55 | 0.74 | 63.39 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 7.03 | 7.60 | 8.56 | 7.10 | 5.63 | |
Quick Ratio (X) | 4.89 | 5.23 | 5.99 | 4.84 | 3.75 | |
Inventory Turnover Ratio (X) | 3.06 | 1.11 | 1.10 | 1.47 | 3.33 | |
Dividend Payout Ratio (NP) (%) | 36.03 | 50.50 | 44.04 | 18.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 30.49 | 40.77 | 37.03 | 16.29 | 0.00 | |
Earnings Retention Ratio (%) | 63.97 | 49.50 | 55.96 | 82.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 69.51 | 59.23 | 62.97 | 83.71 | 0.00 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 149,293.15 | 87,112.88 | 70,821.97 | 114,096.52 | 94,218.02 | |
EV/Net Operating Revenue (X) | 16.23 | 11.37 | 9.29 | 12.85 | 13.86 | |
EV/EBITDA (X) | 44.82 | 34.69 | 26.26 | 28.61 | 32.68 | |
MarketCap/Net Operating Revenue (X) | 16.63 | 11.88 | 9.84 | 13.16 | 14.17 | |
Retention Ratios (%) | 63.96 | 49.49 | 55.95 | 81.99 | 0.00 | |
Price/BV (X) | 10.27 | 6.75 | 5.90 | 10.00 | 10.39 | |
Price/Net Operating Revenue | 16.63 | 11.88 | 9.84 | 13.16 | 14.17 | |
Earnings Yield | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 |
07.08.2025
Accumulate Divis Laboratories; target of Rs 6550: Prabhudas Lilladher
07.08.2025
Divis Labs Standalone June 2025 Net Sales at Rs 2,357.00 crore, up 14.25% Y-o-Y
23.05.2025
Accumulate Divis Laboratories; target of Rs 7518: Deven Choksey
21.05.2025
Reduce Divi's Laboratories: target of Rs 5,610: ICICI Securities
07.08.2025
Divis Labs Standalone June 2025 Net Sales at Rs 2,357.00 crore, up 14.25% Y-o-Y
19.05.2025
Divis Labs Consolidated March 2025 Net Sales at Rs 2,585.00 crore, up 12.24% Y-o-Y
19.05.2025
Divis Labs Standalone March 2025 Net Sales at Rs 2,536.00 crore, up 12.26% Y-o-Y
03.02.2025
Divis Labs Consolidated December 2024 Net Sales at Rs 2,319.00 crore, up 25.01% Y-o-Y
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill